Skip to main content

Agtech Shareholder Update

Written by Customer Service on . Posted in Public Companies.

$AGGL – Agtech Global International Inc.

GENUS™ - CBD products

GENUS™ – CBD products

Newport Beach, California, Nov. 12, 2021 (GLOBE NEWSWIRE) — Agtech Global International Inc., (OTC Pink: AGGL) is a vertically integrated, technology powered CBD manufacturing and online marketing company offering its own range of GENUS™ CBD products through its advanced Virtual Retail Marketing System™, enabled by next generation BlockChain technology. (Name change to Galexxy Corporation pending)

“I am thrilled to provide an update on our significant progress towards our Q1- 2022 and to address the following question” says CEO, Ross Lyndon-James.

In such a competitive market, how will Agtech become successful and achieve increased shareholder value through exponential revenue growth going into 2022 for shareholders?

“We expect to succeed through Bold Innovation, Differentiation and Creative Marketing”

Through our recent corporate reorganization, Agtech is now a multi-faceted company offering science-based products and the latest patented, blockchain technologies to attract and serve a very large customer base. We are offering superior quality products coupled to an outstanding crypto customer rewards program.

In the last few months, we have acquired and are developing:

  • A Unique New Techno-Health Play for Market Domination
  • Inhouse product development and manufacturing capacity
  • New GENUS™ branded CBD based proprietary and blended products
  • Patented VRMS™ platform for installation in over 250,000 retail outlets
  • Free “Business in a Box” marketing App aimed at 2 million Genus brand advocates
  • Blockchain encrypted seed-to-sale operating platform for rapid and secure scaling
  • Blockchain JV for future digital currency trading
  • Blockchain solutions platform for Cannabis and Hemp businesses

Our latest development is a Memorandum of Understanding to acquire a 10% non-dilutable equity shareholding with attaching license rights and revenue participation in KRTL Biotech Inc., an international Psilocybin research and product development company.

Ross Lyndon-James stated that “Investors who got into the cannabis industry early are now looking to medicinal psychedelics as the next big untapped market”. According to Brightfield Group, “It is worth noting that by mid-2021 there were dozens of publicly traded pharmaceutical companies in development phases on psilocybin or psychedelic based products”.

In conclusion, Agtech is pleased to announce that an arrangement is being organized to include non-dilutive financing to fund Agtech’s aggressive marketing plan for accelerated growth.

For further information:

Agtech Global International Inc.
Ross Lyndon-James
E: ross@galexxy.com
M: (949) 456 3972

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “statements”). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release.

https://twitter.com/AgtechGlobal                                                                      

https://www.aggl.net/

                                                              

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.